Deerfield Management Company
Latest statistics and disclosures from Deerfield Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Avexis, GILD, Horizon Pharma, NXTM, Horizon Pharma Plc convertible security, and represent 30.72% of Deerfield Management's stock portfolio.
- Added to shares of these 10 stocks: GILD (+$34.36M), Intersect Ent (+$33.25M), Glaukos (+$29.63M), Mallinckrodt Pub (+$20.15M), PDCO (+$18.46M), MCK (+$14.22M), Aegerion Pharmaceuticals 2% Du cvbond (+$13.45M), Argenx Se (+$10.80M), MOH (+$10.49M), DXCM (+$10.01M).
- Started 11 new stock positions in SEM, Intersect Ent, Argenx Se, Puma Biotechnology Inc Common Stock, Aegerion Pharmaceuticals 2% Du cvbond, Biohaven Pharmaceutical Holding, PDCO, MOH, Arena Pharmaceuticals, Proteostasis Therapeutics In. Mannkind.
- Reduced shares in these 10 stocks: Blueprint Medicines (-$58.88M), Portola Pharmaceuticals (-$57.98M), Endologix Inc note 2.250%12/1 (-$49.07M), Anthem (-$45.68M), Mylan Nv (-$43.68M), Loxo Oncology (-$40.27M), CNC (-$38.71M), Dbv Technologies S A (-$38.50M), Molina Healthcare Inc conv (-$37.10M), EHTH (-$36.66M).
- Sold out of its positions in Acorda Therap note 1.75% 6/15, Adeptus Health Inc-class A, ARRY, Array Biopharma Inc note 3.000% 6/0, Bluebird Bio, CASM, Corvus Pharmaceuticals, Endologix Inc note 2.250%12/1, Five Prime Therapeutics, Genocea Biosciences.
- Deerfield Management was a net seller of stock by $739.89M.
- Deerfield Management has $1.87B in assets under management (AUM), dropping by -27.69%.
Companies in the Deerfield Management portfolio as of June 2017 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Change in Shares | Price |
|---|---|---|---|---|
| Avexis | 10.12 | +3% | 2.31M | 82.16 |
| Gilead Sciences (GILD) | 6.38 | +40% | 1.69M | 70.78 |
| Horizon Pharma | 5.70 | -17% | 9.00M | 11.87 |
| NxStage Medical (NXTM) | 5.13 | +2% | 3.83M | 25.07 |
| Horizon Pharma Plc convertible security | 3.40 | -17% | 74.10M | 0.86 |
| Mylan Nv | 2.83 | -45% | 1.37M | 38.82 |
| Mallinckrodt Pub | 2.82 | +61% | 1.18M | 44.81 |
| McKesson Corporation (MCK) | 2.77 | +37% | 315417 | 164.54 |
| Aerie Pharmaceuticals | 2.69 | +20% | 961147 | 52.55 |
| Isis Pharmaceuticals Inc Del note 1.000%11/1 | 2.39 | -32% | 42.20M | 1.06 |
| Kempharm Inc note 5.500% 2/0 | 2.36 | 75.00M | 0.59 | |
| Flamel Technologies Sa | 2.15 | -10% | 3.66M | 11.03 |
| Trn 4% 04/01/45 | 2.05 | 48.00M | 0.80 | |
| Glaukos | 1.98 | +396% | 894551 | 41.47 |
| Gw Pharmaceuticals Plc ads | 1.93 | -15% | 359983 | 100.25 |
| Endologix, Inc. 3.25% 11/01/2020 | 1.84 | 40.50M | 0.85 | |
| Intersect Ent | 1.77 | NEW | 1.19M | 27.95 |
| Audentes Therapeutics Inc Com stock | 1.76 | +23% | 1.73M | 19.13 |
| Lannett Company (LCI) | 1.66 | -17% | 1.52M | 20.40 |
| Nevro Corp note 1.750% 6/0 | 1.58 | 27.60M | 1.07 | |
| Editas Medicine | 1.53 | 1.71M | 16.78 | |
| Nevro | 1.49 | -6% | 376308 | 74.43 |
| Dbv Technologies S A | 1.27 | -61% | 665197 | 35.71 |
| Portola Pharmaceuticals | 1.26 | -71% | 419000 | 56.17 |
| BioCryst Pharmaceuticals (BCRX) | 1.19 | +29% | 4.00M | 5.56 |
| Intercept Pharmas conv | 1.18 | -47% | 22.50M | 0.98 |
| Selecta Biosciences | 1.12 | 1.06M | 19.86 | |
| Syros Pharmaceuticals | 1.09 | -21% | 1.27M | 16.09 |
| Loxo Oncology | 1.07 | -66% | 251167 | 80.19 |
| Aetna (AET) | 1.05 | -51% | 130000 | 151.83 |
| Patterson Companies (PDCO) | 0.99 | NEW | 393262 | 46.95 |
| Dex (DXCM) | 0.97 | +123% | 247841 | 73.15 |
| Fluidigm Corporation convertible cor | 0.92 | 27.71M | 0.62 | |
| Oxford Immunotec Global | 0.85 | +53% | 945710 | 16.82 |
| Advanced Accelerat spon ads each rep 2 ord shs | 0.82 | -24% | 392904 | 39.04 |
| Galapagos Nv-spon | 0.77 | -27% | 187501 | 76.52 |
| Anthem | 0.75 | -76% | 75182 | 188.13 |
| Wave Life Sciences Ltd shs | 0.74 | +58% | 746841 | 18.60 |
| Aac Holdings | 0.73 | 1.98M | 6.93 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.72 | NEW | 16.60M | 0.81 |
| Recro Pharma | 0.71 | -8% | 1.90M | 7.03 |
| Anaptysbio Inc Common | 0.71 | -34% | 552859 | 23.93 |
| eHealth (EHTH) | 0.69 | -73% | 690348 | 18.80 |
| Xencor | 0.63 | -56% | 562236 | 21.11 |
| Cytomx Therapeutics | 0.63 | -19% | 756822 | 15.50 |
| Ardelyx | 0.62 | +170% | 2.28M | 5.10 |
| Ascendis Pharma A S | 0.62 | -54% | 419453 | 27.76 |
| Axogen | 0.60 | -63% | 674428 | 16.75 |
| Argenx Se | 0.58 | NEW | 509022 | 21.21 |
| Neos Therapeutics | 0.57 | -30% | 1.46M | 7.30 |
| Molina Healthcare (MOH) | 0.56 | NEW | 151665 | 69.18 |
| Blueprint Medicines | 0.55 | -85% | 203000 | 50.67 |
| Aclaris Therapeutics | 0.54 | 375000 | 27.12 | |
| Epizyme | 0.53 | -53% | 662369 | 15.10 |
| Allscripts Healthcare So conv | 0.53 | 9.67M | 1.02 | |
| Sangamo Biosciences (SGMO) | 0.51 | +30% | 1.09M | 8.80 |
| Centene Corporation (CNC) | 0.51 | -80% | 119000 | 79.88 |
| Puma Biotechnology Inc Common Stock | 0.48 | NEW | 104000 | 87.40 |
| Steadymed Ltd shs | 0.48 | -17% | 1.44M | 6.30 |
| Nivalis Therapeutics | 0.48 | 3.73M | 2.41 | |
| Invuity | 0.46 | -30% | 1.18M | 7.25 |
| Select Medical Holdings Corporation (SEM) | 0.41 | NEW | 504632 | 15.35 |
| Arena Pharmaceuticals | 0.38 | NEW | 416729 | 16.87 |
| Alimera Sciences (ALIM) | 0.35 | -18% | 4.77M | 1.39 |
| Axovant Sciences | 0.30 | -57% | 239180 | 23.19 |
| Biohaven Pharmaceutical Holding | 0.29 | NEW | 216761 | 25.00 |
| Myovant Sciences | 0.25 | -43% | 400685 | 11.70 |
| Sierra Oncology | 0.22 | -29% | 3.50M | 1.17 |
| Foamix Pharmaceuticals Ltd shs | 0.20 | 817435 | 4.64 | |
| Akari Therapeutics | 0.20 | -28% | 818158 | 4.61 |
| Myokardia | 0.20 | -34% | 279752 | 13.10 |
| Mannkind | 0.20 | NEW | 2.70M | 1.41 |
| BioScrip (BIOS) | 0.19 | -32% | 1.33M | 2.71 |
| Agile Therapeutics | 0.19 | 955109 | 3.75 | |
| Jounce Therapeutics | 0.19 | -47% | 247872 | 14.03 |
| Kempharm | 0.15 | -35% | 704612 | 4.00 |
| Aralez Pharmaceuticals Inc Com stock | 0.12 | 1.64M | 1.35 | |
| Proteon Therapeutics | 0.10 | -8% | 1.22M | 1.53 |
| Obalon Therapeutics | 0.10 | +773% | 183086 | 9.91 |
| Ra Pharmaceuticals | 0.08 | -53% | 82593 | 18.74 |
| Voyager Therapeutics | 0.06 | 117647 | 8.96 | |
| Essa Pharma | 0.04 | -33% | 1.42M | 0.55 |
| Proteostasis Therapeutics In | 0.00 | NEW | 17251 | 4.70 |
Download CSV 
Past 13F-HR SEC Filings by Deerfield Management
- Deerfield Management 2017 Q1 filed May 15, 2017
- Deerfield Management 2016 Q4 filed Feb. 14, 2017
- Deerfield Management 2016 Q3 filed Nov. 14, 2016
- Deerfield Management 2016 Q2 filed Aug. 15, 2016
- Deerfield Management 2016 Q1 filed May 16, 2016
- Deerfield Management 2015 Q4 filed Feb. 16, 2016
- Deerfield Management 2015 Q3 filed Nov. 16, 2015
- Deerfield Management 2015 Q1 filed May 15, 2015
- Deerfield Management 2014 Q4 filed Feb. 17, 2015
- Deerfield Management 2014 Q3 filed Nov. 14, 2014
- Deerfield Management 2014 Q2 filed Aug. 14, 2014
- Deerfield Management 2014 Q1 filed May 15, 2014
- Deerfield Management 2013 Q4 filed Feb. 14, 2014
- Deerfield Management 2013 Q3 filed Nov. 14, 2013
- Deerfield Management Co /ny 2013 Q2 filed Aug. 14, 2013
- Deerfield Management Company 2013 Q1 filed May 14, 2013
- Deerfield Management Company 2012 Q4 filed Feb. 14, 2013
- Deerfield Management Company 2012 Q3 filed Nov. 14, 2012
- Deerfield Management Company 2012 Q1 filed May 15, 2012